Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123187893 | 12318789 | 3 | F | 20160218 | 20160708 | 20160429 | 20160715 | EXP | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-030871 | BRISTOL MYERS SQUIBB | 66.29 | YR | M | Y | 0.00000 | 20160715 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123187893 | 12318789 | 1 | PS | SPRYCEL | DASATINIB | 1 | Oral | 140 MG, QD | 61320 | MG | Y | 21986 | 140 | MG | QD | ||||
| 123187893 | 12318789 | 2 | SS | SPRYCEL | DASATINIB | 1 | Oral | 140 MG, QD | 61320 | MG | Y | 21986 | 140 | MG | QD | ||||
| 123187893 | 12318789 | 3 | SS | SPRYCEL | DASATINIB | 1 | Oral | 140 MG, QD | 61320 | MG | Y | 21986 | 140 | MG | QD | ||||
| 123187893 | 12318789 | 4 | C | GABAPENTIN. | GABAPENTIN | 1 | Oral | 300 MG, QD | U | 0 | 300 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123187893 | 12318789 | 1 | Chronic myeloid leukaemia |
| 123187893 | 12318789 | 4 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123187893 | 12318789 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123187893 | 12318789 | Ascites | |
| 123187893 | 12318789 | Dyspnoea | |
| 123187893 | 12318789 | Fatigue | |
| 123187893 | 12318789 | Localised oedema | |
| 123187893 | 12318789 | Mood altered | |
| 123187893 | 12318789 | Pleural effusion | |
| 123187893 | 12318789 | Pulmonary oedema | |
| 123187893 | 12318789 | Weight decreased | |
| 123187893 | 12318789 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123187893 | 12318789 | 1 | 20141209 | 0 | ||
| 123187893 | 12318789 | 2 | 20141208 | 20160507 | 0 | |
| 123187893 | 12318789 | 3 | 20141112 | 0 |